Skip to main content

Diagnostic options Β· UAE

Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 721–735 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-3210
t(4;11)(q21;q23) [MLL-AF4] Fusion Transcript PCR Qualitative Test

This diagnostic test evaluates for the presence of the MLL-AF4 fusion transcript, a specific genetic rearrangement associated with high-risk acute lymphoblastic leukemia (ALL).

Bone marrow aspirate (preferred) or 3 mL peripheral whole blood in lavender EDTA tube 48–72 hours 650.00 AED
View
View test specifications and preparation
What it measures
["MLL-AF4 fusion transcript", "t(4;11)(q21;q23) translocation"]
Parameters
[{"name": "Methodology", "reference_range": "Real-Time PCR with melt curve analysis"}, {"name": "Sensitivity", "reference_range": "Detects 1 leukemic cell in 10,000 (10⁻⁴)"}]
Preparation
["No specific patient preparation required"]
Indications
["Diagnosis of acute lymphoblastic leukemia (ALL)", "Risk stratification in ALL", "Guiding treatment decisions in ALL"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92870-7 ICD-10: C91.00
Clinical summary
This diagnostic test evaluates for the presence of the MLL-AF4 fusion transcript, a specific genetic rearrangement associated with high-risk acute lymphoblastic leukemia (ALL).
TEST-3219
Tacrolimus Genotyping (CYP3A5) Test

This test evaluates genetic variations in the CYP3A5 gene that affect the metabolism of the immunosuppressant drug tacrolimus.

Peripheral whole blood 4–5 working days 1,000.00 AED
View
View test specifications and preparation
What it measures
["CYP3A5 gene polymorphisms", "Tacrolimus metabolism rate prediction"]
Parameters
[]
Preparation
["No fasting required", "No special preparation needed"]
Indications
["Pre-therapy dose individualisation for kidney transplant recipients", "Pre-therapy dose individualisation for liver transplant candidates", "Pre-therapy dose individualisation for heart transplant candidates", "Patients requiring long-term tacrolimus therapy with elevated risk of toxicity or subtherapeutic exposure"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 69071-2 ICD-10: Z13.89
Clinical summary
This test evaluates genetic variations in the CYP3A5 gene that affect the metabolism of the immunosuppressant drug tacrolimus.
TEST-4212
TAF1 Gene DYT3 Genetic Test

This test identifies pathogenic variants in the TAF1 gene associated with X-linked dystonia-parkinsonism (Lubag disease).

Whole Blood (Venipuncture or FTA Card), Extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TAF1 gene", "Presence of mutations causing X-linked dystonia-parkinsonism"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medication unless advised by physician"]
Indications
["Suspected X-linked dystonia-parkinsonism (DYT3)", "Family history of DYT3", "Differential diagnosis of movement disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101376-3 ICD-10: G24.8, Z15.89, Z13.850
Clinical summary
This test identifies pathogenic variants in the TAF1 gene associated with X-linked dystonia-parkinsonism (Lubag disease).
TEST-1092
Targeted Mutation Analysis (2 Mutations) Test

This test detects the presence or absence of two specific DNA sequence variants using Sanger sequencing.

Peripheral blood, plasma, serum, amniotic fluid, cord blood, chorionic villi 10–15 days from collection 2,000.00 AED
View
View test specifications and preparation
What it measures
["Specific DNA sequence variants", "Gene mutations"]
Parameters
[]
Preparation
["Follow physician's advice regarding temporary pausing of certain supplements"]
Indications
["Hereditary breast/ovarian cancer syndromes", "Prenatal diagnosis", "Genetic rheumatic disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81263-9 ICD-10: Z13.89
Clinical summary
This test detects the presence or absence of two specific DNA sequence variants using Sanger sequencing.
TEST-1085
Targeted Mutation Analysis (More than 2 Mutations) Test

This test identifies specific pathogenic variants in pre-selected genes associated with hereditary syndromes.

Peripheral Blood (Whole Blood) 10-15 business days 2,600.00 AED
View
View test specifications and preparation
What it measures
["Specific pathogenic DNA variants", "Mutations in genes like BRCA1/2"]
Parameters
[]
Preparation
["No specific fasting required", "Continue prescribed medications unless instructed otherwise"]
Indications
["Assessment of hereditary cancer risk", "Diagnosis of inherited disorders like thalassemia", "Presurgical clearance", "Pregnancy-related screening", "Travel abroad requirements"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55233-1 ICD-10: Z13.89
Clinical summary
This test identifies specific pathogenic variants in pre-selected genes associated with hereditary syndromes.
TEST-233
Targeted Sequencing (Below 50 Kb) Test

This test evaluates specific, clinically actionable regions of the genome using extracted DNA to identify low-frequency variants.

Extracted DNA (Whole Blood) 10 Weeks 150,000.00 AED
View
View test specifications and preparation
What it measures
["Specific genomic regions
Parameters
[]
Preparation
[]
Indications
["Precision oncology protocols", "Minimal residual disease monitoring", "Research-grade hypothesis validation"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82323-6 ICD-10: Z13.89
Clinical summary
This test evaluates specific, clinically actionable regions of the genome using extracted DNA to identify low-frequency variants.
TEST-3706
TBCE Gene Hypoparathyroidism‑Retardation‑Dysmorphism (HRD) Syndrome Genetic Test

This genetic test analyzes the TBCE gene to identify mutations associated with Sanjad-Sakati syndrome (HRD syndrome). It confirms the molecular basis for hypoparathyroidism, develo...

Peripheral Whole Blood or Buccal Swab 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TBCE gene", "Coding region sequence of the TBCE gene"]
Parameters
[]
Preparation
["No fasting required", "No specific medication or diet restrictions"]
Indications
["Suspected Sanjad-Sakati syndrome (HRD syndrome)", "Hypoparathyroidism with developmental delay and dysmorphic features", "Family history of HRD syndrome"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81262-6 ICD-10: Q87.8, E20.0
Clinical summary
This genetic test analyzes the TBCE gene to identify mutations associated with Sanjad-Sakati syndrome (HRD syndrome). It confirms the molecular basis for hypoparathyroidism, developmental delay, and dysmorphic features.
TEST-4408
TBX20 Gene Atrial Septal Defect Type 4 Genetic Test

This test evaluates the TBX20 gene for mutations associated with Atrial Septal Defect Type 4 (ASD4). It uses Next Generation Sequencing (NGS) to detect pathogenic variants.

Peripheral Whole Blood 3–4 Weeks (21–28 Business Days) 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic single-nucleotide variants in TBX20", "Insertions and deletions in TBX20 coding region", "Splice-site boundaries of TBX20"]
Parameters
[]
Preparation
["No specific fasting required.", "Inform physician about known interfering medications."]
Indications
["Diagnosis of Atrial Septal Defect Type 4 (ASD4)", "Family cascade screening for TBX20-related ASD4", "Guiding clinical management decisions for ASD4"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48018-6 ICD-10: Q21.1
Clinical summary
This test evaluates the TBX20 gene for mutations associated with Atrial Septal Defect Type 4 (ASD4). It uses Next Generation Sequencing (NGS) to detect pathogenic variants.
TEST-3202
TCF3-PBX1 Fusion Gene Qualitative PCR Test

This test detects the presence or absence of the TCF3-PBX1 fusion gene in a blood sample.

Peripheral Blood (Whole Blood) 2–3 Business Days (Sample submission Mon/Thu before 11 AM yields report Wed/Sat; other times +1 day) 650.00 AED
View
View test specifications and preparation
What it measures
["TCF3-PBX1 fusion gene presence"]
Parameters
[{"name": "TCF3-PBX1 Fusion Gene", "reference_range": "Negative/Positive"}]
Preparation
["Provide mandatory clinical history.", "Avoid sample freezing."]
Indications
["Diagnosis of B-cell acute lymphoblastic leukemia (B-ALL)", "Risk stratification in B-ALL", "Guiding treatment decisions in B-ALL"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 79556-2 ICD-10: C91.00
Clinical summary
This test detects the presence or absence of the TCF3-PBX1 fusion gene in a blood sample.
TEST-1075
TEL/AML1 (ETV6-RUNX1) Fusion Quantitative PCR Test

This test detects and quantifies the TEL/AML1 fusion transcript, a genetic marker associated with B-cell precursor ALL.

Bone Marrow Aspirate or Peripheral Blood 3-4 Business Days 800.00 AED
View
View test specifications and preparation
What it measures
["TEL/AML1 fusion transcript", "Minimal Residual Disease (MRD)"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of B-cell precursor ALL", "Risk stratification in ALL", "Monitoring treatment response in ALL", "Minimal Residual Disease (MRD) monitoring"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 76518-9 ICD-10: C91.0
Clinical summary
This test detects and quantifies the TEL/AML1 fusion transcript, a genetic marker associated with B-cell precursor ALL.
TEST-440
Telomere Age Testing Test

This test evaluates the length of telomeres in white blood cells to estimate biological age.

Peripheral Blood (Leukocytes) 8–10 Business Days 3,000.00 AED
View
View test specifications and preparation
What it measures
["Telomere length in leukocytes", "Telomere-to-single copy gene (T/S) ratio"]
Parameters
[{"name": "Telomere Length (T/S Ratio)", "reference_range": "Percentile score relative to age cohort"}]
Preparation
["No fasting required", "Avoid strenuous exercise for 24 hours before collection", "Continue all prescribed medications and supplements"]
Indications
["Assessment of biological age", "Monitoring anti-aging interventions", "Screening for accelerated aging syndromes"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 86944-5 ICD-10: Z13.89
Clinical summary
This test evaluates the length of telomeres in white blood cells to estimate biological age.
TEST-3224
TERT Gene Germline Mutation Analysis for AML Susceptibility (NGS) Test

This test evaluates for inherited pathogenic variants in the TERT gene, which are associated with an increased lifetime risk of developing acute myeloid leukemia (AML).

Whole Blood (5 mL EDTA) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["TERT gene germline mutations", "Pathogenic variants associated with AML predisposition"]
Parameters
[]
Preparation
["No fasting is necessary."]
Indications
["Individuals with a family history of AML or related bone marrow disorders.", "Patients seeking proactive risk assessment for AML."]
Measurement technique
Confirm with laboratory
Codes
LOINC: 88253-5 ICD-10: Z15.09
Clinical summary
This test evaluates for inherited pathogenic variants in the TERT gene, which are associated with an increased lifetime risk of developing acute myeloid leukemia (AML).
TEST-1964
TET2 Gene Myelodysplastic Syndrome (Somatic) Genetic Test

This test detects acquired somatic mutations within the TET2 gene, which are associated with myelodysplastic syndromes.

Peripheral whole blood (EDTA) or extracted genomic DNA 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Acquired somatic mutations in the TET2 gene", "Epigenetic regulation"]
Parameters
[]
Preparation
["Pre-test genetic counselling session is mandatory."]
Indications
["Diagnosis of myelodysplastic syndromes", "Prognosis assessment in MDS", "Therapeutic stratification in MDS", "Refining IPSS-R risk scores"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 86204-6 ICD-10: D46.9, D46.2, D46.0, Z15.09
Clinical summary
This test detects acquired somatic mutations within the TET2 gene, which are associated with myelodysplastic syndromes.
TEST-4485
TFG Gene Hereditary Motor and Sensory Neuropathy, Okinawa Type Genetic Test

This test identifies pathogenic variants in the TFG gene associated with Hereditary Motor and Sensory Neuropathy, Okinawa Type (HMSN‑P). It confirms the diagnosis at the molecular...

Peripheral Whole Blood 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TFG gene"]
Parameters
[]
Preparation
["Attend a genetic counselling session.", "Stay hydrated on the day of the blood draw."]
Indications
["Suspected Hereditary Motor and Sensory Neuropathy, Okinawa Type (HMSN‑P)", "Family history of HMSN‑P"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: G60.0
Clinical summary
This test identifies pathogenic variants in the TFG gene associated with Hereditary Motor and Sensory Neuropathy, Okinawa Type (HMSN‑P). It confirms the diagnosis at the molecular level.
TEST-6296
TFR2 Gene Hemochromatosis Type 3 Genetic Test

This test evaluates the TFR2 gene for pathogenic variants associated with hereditary hemochromatosis type 3, a condition causing iron overload.

Peripheral whole blood 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TFR2 gene", "Copy Number Variants (CNVs) in the TFR2 gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform genetic counsellor about recent blood transfusion (less than 2 weeks) or current iron chelation therapy"]
Indications
["Diagnosis of hereditary hemochromatosis type 3", "Cascade screening of family members"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94086-5 ICD-10: E83.110
Clinical summary
This test evaluates the TFR2 gene for pathogenic variants associated with hereditary hemochromatosis type 3, a condition causing iron overload.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area